University of Miami Clinical Psychopharmacology: Beyond Conventional Wisdom 2026
ONly Videos no PDFs
Feb 16 – 20, 2026
OVERVIEW
Clinical Psychopharmacology: Beyond Conventional Wisdom is organized by University of Miami Miller School of Medicine Division of Continuing Medical Education and will be held from Feb 16 – 20, 2026 at The Sunny Miami Sunny Isles Beach, Curio Collection by Hilton, Sunny Isles Beach, Florida, United States of America.
Description:
This seminar aims to enhance clinicians’ expertise in psychopharmacology by thoroughly exploring key concepts and contemporary practices. Participants will engage with a variety of conceptual models, comparing symptom-oriented and disease-oriented treatment approaches. We will critically evaluate the diagnostic validity of major psychiatric conditions and investigate evidence-based medication strategies tailored to these disorders.
Course Description:
- The presentation places a strong emphasis on diagnostic accuracy and the application of research-driven clinical practices, prioritizing efficacy and safety as demonstrated in clinical trials over speculative biological mechanisms. In-depth analysis and treatment strategies will be provided for schizophrenia, bipolar disorder, depression, and anxiety disorders, with additional focus on mixed states, bipolar depression, and the nuanced role of psychopharmacology in optimizing treatment outcomes
- The seminar will incorporate the latest research findings, including recent advancements in clinical psychopharmacology, to ensure participants are equipped with up-to-date knowledge and skills. Special attention will be given to the application of these strategies in diverse patient populations, including children, the elderly, and those with comorbid medical conditions, to promote holistic and effective patient care.
Objectives:
Upon completion of this activity, participants will be able to:
- Describe the historical background on the major themes to be covered during the course.
- Examine the biological mechanisms of major psychotropic drug classes.
- Grasp the basic neuroanatomy relevant to clinical psychopharmacology.
- Recognize and apply key clinical trials of drug classes for various diagnoses.
- Examine the validity of DSM diagnoses and learn how to use non-DSM approaches to diagnosis and drug treatment.
- Discuss practices with antipsychotics, mood stabilizers, and antidepressants.
- Explain the risks and side effects of major drug classes.
- Employ medications with an understanding of pharmacokinetic interactions.
- Identify factors in medication use for those with comorbid medical conditions.
| Sr. No. | Title | Duration | Speaker |
|---|---|---|---|
| 1 | Bipolar Depression and Mixed States: Why Antidepressants Fail and Dopamine Blockers Work | 17:22 | Nassir Ghaemi |
| 2 | Mood Stabilizers in Bipolar Disorder: Limitations of Anticonvulsants vs Lithium | 42:10 | Nassir Ghaemi |
| 3 | How Mood Temperaments Drive Misdiagnosis in Psychiatry | 30:02 | Nassir Ghaemi |
| 4 | Treating Mood Temperaments to Improve Mental Health Outcomes | 21:05 | Nassir Ghaemi |
| 5 | Antipsychotic Safety: Neurotoxicity, Akathisia, and Tardive Dyskinesia Risks | 43:58 | Nassir Ghaemi |
| 6 | Lithium in Mood Disorders: Is It the Safest Mood Stabilizer? | 56:20 | Nassir Ghaemi |
| 7 | Lithium Safety and Renal Effects: Interpreting eGFR and True Kidney Risk | 11:42 | Nassir Ghaemi |
| 8 | Antipsychotics in Schizophrenia: Short-Term Symptom Control vs Long-Term Outcomes | 06:24 | Nassir Ghaemi |
| 9 | Antipsychotic-Induced Akathisia and EPS: Clinical Risks and Management | 20:41 | Nassir Ghaemi |
| 10 | Antipsychotics and Metabolic Risk: Insulin Resistance, Weight Gain, & More | 05:54 | Nassir Ghaemi |
| 11 | Bipolar Mania Management With Antipsychotics: Acute Efficacy vs Maintenance Limitations | 09:39 | Nassir Ghaemi |
| 12 | ADHD: Clinical Efficacy and Safety of Amphetamine-Based Therapies | 54:33 | Nassir Ghaemi |
| 13 | Antidepressant Safety Risks: Suicidality, Cardiovascular Effects, and Withdrawal Syndromes | 30:43 | Nassir Ghaemi |
| 14 | MDD Maintenance Treatment: Do Antidepressants Sustain Remission? | 20:17 | Nassir Ghaemi |
| 15 | Acute Treatment of Major Depressive Disorder: Interpreting Effect Size, Placebo Response, and Clinical Meaningfulness | 38:58 | Nassir Ghaemi |
| 16 | Do Antidepressants Work in Bipolar Depression or Worsen Outcomes? | 18:14 | Nassir Ghaemi |
| 17 | Basic Concepts of Psychopharmacology for the Clinician | 29:58 | Nassir Ghaemi |
| 18 | Neurobiology in Psychopharmacology: Why Mechanisms Matter Less Than Clinical Outcomes | 12:20 | Nassir Ghaemi |
| 19 | Antipsychotic Psychopharmacology: Receptor Affinity, Dosing, and Adverse Effects | 15:08 | Nassir Ghaemi |
| 20 | Mood Stabilizer Neurobiology: Lithium and Antiepileptics Mechanisms | 05:14 | Nassir Ghaemi |
| 21 | Psychopharmacology of Monoamine Agonists From Chemical Structure to Clinical Effect | 16:02 | Nassir Ghaemi |
| 22 | Benzodiazepines & Alternatives for Sleep and Anxiety Disorders: Pharmacology & Adverse Effects | 09:02 | Nassir Ghaemi |



